Related references
Note: Only part of the references are listed.Obesity-induced lysine acetylation increases cardiac fatty acid oxidation and impairs insulin signalling
Osama Abo Alrob et al.
CARDIOVASCULAR RESEARCH (2014)
Body Mass Index and Mortality in Acutely Decompensated Heart Failure Across the World
Ravi Shah et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
ANG II causes insulin resistance and induces cardiac metabolic switch and inefficiency: a critical role of PDK4
Jun Mori et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2013)
Pressure-overload-induced heart failure induces a selective reduction in glucose oxidation at physiological afterload
Pavel Zhabyeyev et al.
CARDIOVASCULAR RESEARCH (2013)
Cardiac Insulin-Resistance and Decreased Mitochondrial Energy Production Precede the Development of Systolic Heart Failure After Pressure-Overload Hypertrophy
Liyan Zhang et al.
CIRCULATION-HEART FAILURE (2013)
Constitutive STAT3 Phosphorylation Contributes to Skeletal Muscle Insulin Resistance in Type 2 Diabetes
Fredirick Mashili et al.
DIABETES (2013)
Sirt3 Regulates Metabolic Flexibility of Skeletal Muscle Through Reversible Enzymatic Deacetylation
Enxuan Jing et al.
DIABETES (2013)
Effects of weight loss on myocardial energetics and diastolic function in obesity
O. J. Rider et al.
INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING (2013)
Carnitine Palmitoyltransferase-1b Deficiency Aggravates Pressure Overload-Induced Cardiac Hypertrophy Caused by Lipotoxicity
Lan He et al.
CIRCULATION (2012)
Cardiac-Specific Deletion of Acetyl CoA Carboxylase 2 Prevents Metabolic Remodeling During Pressure-Overload Hypertrophy
Stephen C. Kolwicz et al.
CIRCULATION RESEARCH (2012)
Dietary Fat and Heart Failure: Moving From Lipotoxicity to Lipoprotection
William C. Stanley et al.
CIRCULATION RESEARCH (2012)
Agonist-Induced Hypertrophy and Diastolic Dysfunction Are Associated With Selective Reduction in Glucose Oxidation A Metabolic Contribution to Heart Failure With Normal Ejection Fraction
Jun Mori et al.
CIRCULATION-HEART FAILURE (2012)
A maternal high-fat diet modulates fetal SIRT1 histone and protein deacetylase activity in nonhuman primates
Melissa A. Suter et al.
FASEB JOURNAL (2012)
Regulation of Insulin and Leptin Signaling by Muscle Suppressor of Cytokine Signaling 3 (SOCS3)
Zhenggang Yang et al.
PLOS ONE (2012)
p38 beta MAPK upregulates atrogin1/MAFbx by specific phosphorylation of C/EBP beta
Guohua Zhang et al.
SKELETAL MUSCLE (2012)
Cardiac diacylglycerol accumulation in high fat-fed mice is associated with impaired insulin-stimulated glucose oxidation
Liyan Zhang et al.
CARDIOVASCULAR RESEARCH (2011)
Impact of Leptin-Mediated Sympatho-Activation on Cardiovascular Function in Obese Mice
Eric J. Belin de Chantemele et al.
HYPERTENSION (2011)
The Deacetylase SIRT1 Promotes Membrane Localization and Activation of Akt and PDK1 During Tumorigenesis and Cardiac Hypertrophy
Nagalingam R. Sundaresan et al.
SCIENCE SIGNALING (2011)
Decreased rates of substrate oxidation ex vivo predict the onset of heart failure and contractile dysfunction in rats with pressure overload
Torsten Doenst et al.
CARDIOVASCULAR RESEARCH (2010)
Inhibition of De Novo Ceramide Synthesis Reverses Diet-Induced Insulin Resistance and Enhances Whole-Body Oxygen Consumption
John R. Ussher et al.
DIABETES (2010)
PGC-1α Serine 570 Phosphorylation and GCN5-mediated Acetylation by Angiotensin II Drive Catalase Down-regulation and Vascular Hypertrophy
Shiqin Xiong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
SIRT4 Regulates Fatty Acid Oxidation and Mitochondrial Gene Expression in Liver and Muscle Cells
Nargis Nasrin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation
Matthew D. Hirschey et al.
NATURE (2010)
Myocardial Fatty Acid Metabolism in Health and Disease
Gary D. Lopaschuk et al.
PHYSIOLOGICAL REVIEWS (2010)
Regulation of Cellular Metabolism by Protein Lysine Acetylation
Shimin Zhao et al.
SCIENCE (2010)
Body Mass Index and Vigorous Physical Activity and the Risk of Heart Failure Among Men
Satish Kenchaiah et al.
CIRCULATION (2009)
Resveratrol Prevents the Prohypertrophic Effects of Oxidative Stress on LKB1
Vernon W. Dolinsky et al.
CIRCULATION (2009)
Insulin-Stimulated Cardiac Glucose Oxidation Is Increased in High-Fat Diet-Induced Obese Mice Lacking Malonyl CoA Decarboxylase
John R. Ussher et al.
DIABETES (2009)
Body mass index and mortality in heart failure: A meta-analysis
Antigone Oreopoulos et al.
AMERICAN HEART JOURNAL (2008)
Hypertrophic cardiomyopathy in high-fat diet-induced obesity: role of suppression of forkhead transcription factor and atrophy gene transcription
Cindy X. Fang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Atrogin-1 ubiquitin ligase is upregulated by doxorubicin via p38-MAP kinase in cardiac myocytes
Yasuhiro Yamamoto et al.
CARDIOVASCULAR RESEARCH (2008)
Cardiac energy metabolism in obesity
Gary D. Lopaschuk et al.
CIRCULATION RESEARCH (2007)
Mechanisms of disease - The failing heart - An engine out of fuel
Stefan Neubauer
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Long-term activation of adenosine monophosphate-activated protein kinase attenuates pressure-overload-induced cardiac hypertrophy
Hong-Liang Li et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
Foxo transcription factors blunt cardiac hypertrophy by inhibiting calcineurin signaling
Yan G. Ni et al.
CIRCULATION (2006)
GCN5 acetyltransferase complex controls glucose metabolism through transcriptional repression of PGC-1α
Caries Lerin et al.
CELL METABOLISM (2006)
Long-term cardiovascular consequences of obesity: 20-year follow-up of more than 15000 middle-aged men and women (the Renfrew-Paisley study)
NF Murphy et al.
EUROPEAN HEART JOURNAL (2006)
Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity
J Buchanan et al.
ENDOCRINOLOGY (2005)
Suppression of FOXO1 activity by FHL2 through SIRT1-mediated deacetylation
YH Yang et al.
EMBO JOURNAL (2005)
The obesity paradox - Body mass index and outcomes in patients with heart failure
JP Curtis et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Effect of obesity and being overweight on long-term mortality in congestive heart failure: influence of left ventricular systolic function
F Gustafsson et al.
EUROPEAN HEART JOURNAL (2005)
Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy
M Sandri et al.
CELL (2004)
Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase
A Brunet et al.
SCIENCE (2004)
Mammalian SIRT1 represses forkhead transcription factors
MC Motta et al.
CELL (2004)
Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse
K Ueki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity
H Daitoku et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms
K Ueki et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women
LR Peterson et al.
CIRCULATION (2004)
Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes
JJ Senn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Body composition and prognosis in chronic systolic heart failure: The obesity paradox
CJ Lavie et al.
AMERICAN JOURNAL OF CARDIOLOGY (2003)
Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study
SD Anker et al.
LANCET (2003)
Body mass and survival in patients with chronic heart failure without cachexia: The importance of obesity
CH Davos et al.
JOURNAL OF CARDIAC FAILURE (2003)
Obesity and the risk of heart failure
S Kenchaiah et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
SOCS-3 inhibits insulin signaling and is up-regulated in response to tumor necrosis factor-α in the adipose tissue of obese mice
B Emanuelli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Stimulation of glucose transport by AMP-activated protein kinase via activation of p38 mitogen-activated protein kinase
X Xi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
p90-RSK and Akt may promote rapid phosphorylation/inactivation of glycogen synthase kinase 3 in chemoattractant-stimulated neutrophils
DD De Mesquita et al.
FEBS LETTERS (2001)
M-mode echocardiographic predictors at six- to seven-year incidence of coronary heart disease, stroke, congestive heart failure, and mortality in an elderly cohort (the Cardiovascular Health Study)
JM Gardin et al.
AMERICAN JOURNAL OF CARDIOLOGY (2001)
Obesity cardiomyopathy: Pathophysiology and evolution of the clinical syndrome
MA Alpert
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2001)
Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A
XJ Fang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
